We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Ultrasound and Blood Test May Increase Survival After Myocardial Infarction

By LabMedica International staff writers
Posted on 26 Apr 2011
Two comparatively simple techniques, an ultrasound investigation and a blood test to measure the level of a substance known as of B-type natriuretic peptide (BNP), can predict survival and future heart failure following acute coronary syndromes. More...


This is the conclusion of a thesis presented at the University of Gothenburg's Sahlgrenska Academy (Sweden). Acute coronary syndromes, such as myocardial infarction and unstable angina, are among the most common causes of emergency medical care and death in Sweden for both women and men. "The ability to predict the future course of the syndrome in a patient may improve the possibility of providing extra preventative treatment for those with the highest risks. Or, and this may be more important, the possibility of following these patients with more frequent checkups in order to detect early whether the patient's health is deteriorating," said biomedical scientist, Dr. Anita Persson.

The research on which the thesis is based demonstrated that elevated levels in the blood were associated not only with an impaired ability of the heart to pump blood, but also with the risk of rehospitalization due to heart failure following acute coronary syndromes, and premature death. One noteworthy finding was that the correlation between high BNP and future risk was present also for those patients who did not show signs of heart failure during the first acute episode.

The other technology that Dr. Persson has evaluated is the use of ultrasound, in a technique known as Doppler echocardiography, to evaluate leakage at one of the valves in the heart. It proved to be the case that the ultrasound investigation can predict not only increased mortality but also increased rehospitalization due to heart failure. She discovered, by comparing many different characteristics of the function of the heart determined by Doppler echocardiography, that an increased volume of the left ventricle and increased pressure during the filling phase of the heart action or increased stiffness of the ventricle were linked with a poorer prognosis and an increased risk of complications.

The study is based on a large group of patients with acute coronary syndromes who received care between September 1995 and March 2001 in the coronary care unit at Sahlgrenska University Hospital. "Including the echocardiography variables on their own or in combination with the level of BNP in the risk assessment can be a relatively simple means of identifying high-risk patients and those who have the best preconditions for avoiding complications," remarked Dr. Persson.

The thesis was presented for the degree of doctor of philosophy (medicine) at the Institute of Medicine, Sahlgrenska Academy at the University of Gothenburg.

Related Links:

University of Gothenburg's Sahlgrenska Academy





Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
Thyroid Test
Anti-Thyroid EIA Test
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New findings demonstrate that anti-Müllerian hormone (AMH) may help identify which breast cancer patients are most likely to benefit from chemotherapy plus endocrine therapy (Image Credit: Shutterstock)

AMH Test Helps Predict Adjuvant Chemotherapy Benefit in Premenopausal Breast Cancer

Hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer can present a difficult treatment decision in premenopausal patients with low recurrence scores.... Read more

Molecular Diagnostics

view channel
Image Credit: iStock

Sequencing-Based Newborn Screening Identifies Pediatric Cancer Risk at Birth

Newborn screening in the United States relies on heel-stick blood spots to identify rare, treatable disorders through biochemical testing, but these programs generally do not assess inherited cancer risk... Read more

Microbiology

view channel
Image: The QIAstat-Dx BCID GPF Plus AMR Panel is the first QIAstat-Dx panel for bloodstream infections to receive FDA clearance (Photo courtesy of Qiagen)

FDA Clears One-Hour Panel for Bloodstream Infection and AMR Detection

Bloodstream infections can rapidly progress to sepsis, a life-threatening condition affecting an estimated 1.7 million adults in the U.S. each year. Rapid identification of pathogens and antimicrobial... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.